FindTrial
Sign In

Effect of Cupping and Plantain Seeds versus Tranexamic Acid in Women in women with Heavy Menstrual Bleeding.

Efficacy of Hijama Bila Shart and Tukhm Bartang versus Tranexamic Acid in Women with Kathrat-i-Hayd. - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/01/079255
Enrollment
62
Registered
2025-01-23
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N920- Excessive and frequent menstruation with regular cycle

Interventions

Intervention1: Tukhm Bartang (Plantago major L.) and Hijama bila Shart: Tukhm Bartang will be given orally 5g will be given in three divided doses for 5 days from first day of menstruation. 2 large cu

Sponsors

National Institute of Unani Medicine
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Study participants in the age group of 18-42 years with regular cycles (21-35 days) with MBL greater than 80 ml or DOB greater than 7 days for 2 out of 3 consecutive cycles. Study participants with PBAC scores greater than 80ml and Samanta scores more than 3. Study participants with thickened endometrium up to 18 mm, adenomyosis,uterine fibroids less than 3 in number and less than 3 cm in size. Study participants with mild (Hb levels 11-11.9g/dL) to moderate (Hb levels 8 to 10.9.9g/dL) anemia.

Exclusion criteria

Exclusion criteria: Study participants with co-morbidities such as uncontrolled hypertension (Stage 2 hypertension more than 140/90 mmHg), uncontrolled diabetes mellitus (FBS more than 130mg/dl or PPBS more than 180mg/dl or RBS more than 200mg/dl or HbA1c more than 7.00%), uncontrolled hypothyroid, Bleeding disorders, severe anaemia (Hb less than 8gm%) and malignancy. Hormonal contraceptives in last 3 months. Study participants with uterine fibroid more than 3 in number and more than 3 cm in size.

Design outcomes

Primary

MeasureTime frame
PBLAC (Pictorial Blood Loss Assessment Chart)Timepoint: PBLAC (Pictorial Blood Loss Assessment Chart) will be assessed at baseline, week 4, 8, 12 and week 16—

Secondary

MeasureTime frame
Samanta questionnaire, MIQ (Menorrhagia Impact Questionnaire), Haemoglobin percentageTimepoint: The secondary outcome Samanta & MIQ will assessed after menstruation at baseline, week 4, week 8, 12 & week 16. Haemoglobin percentage will be assessed at baseline & week 12.—

Countries

India

Contacts

Public ContactPROF DR ARSHIYA SULTANA

National Institute of Unani Medicine

ramshaarshad21@gmail.com9109645156

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026